Abstract:9 examples) including novel triazolylphthalimides are synthesized by amination of phthalic anhydride. All the compounds obtained possess hypolipidemic activity. Compound (IIIb), the most active one, displays an excellent and quite promising hypolipidemic activity. -(SENA, V. L. M.; SRIVASTAVA*, R. M.; SILVA, R. O.; LIMA, V. L. M.; Farmaco 58 (2003) 12, 1283-1288; Dep. Quim. Fundam., Univ. Fed. Pernambuco, 50670 Recife, Brazil; Eng.) -M. Kowall 13-068
“…Imides synthesis is of widespread interest as several derivatives of this heterocyclic unit have been found to possess important applications in biology [1][2][3][4][5][6][7], synthetic [8][9][10] and polymer chemistry [11].…”
Section: Introductionmentioning
confidence: 99%
“…Phthalimides are directly obtained from these general methods, but they have also been obtained from a number of unusual starting materials and methods [3][4][5][6][12][13][14][15][16]. The reaction of potassium phthalimide with halogenoalkanes and with a variety of other alkylating agents leads to N-alkylphthalimide.…”
This paper synthesizes N -substituted phthalimides derived from nitrogen heterocycles as potential 5-HT 4 ligands by using the Mitsunobu reaction. Conformational studies of some of the new compounds have been conducted using 1 H and 13 C-NMR spectroscopy. Proton and carbon resonances were achieved through the application of onedimensional selective NOE, two-dimensional NMR techniques -homonuclear COSY-45, NOESY and heteronuclear 1 H-13 C HMQC correlated spectroscopy-and double resonance experiments. The crystal structure of compound 1 was determined by X-ray diffraction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.